TY  - GEN
AU  - Mercer,B M
AU  - Miodovnik,M
AU  - Thurnau,G R
AU  - Goldenberg,R L
AU  - Das,A F
AU  - Ramsey,R D
AU  - Rabello,Y A
AU  - Meis,P J
AU  - Moawad,A H
AU  - Iams,J D
AU  - Van Dorsten,J P
AU  - Paul,R H
AU  - Bottoms,S F
AU  - Merenstein,G
AU  - Thom,E A
AU  - Roberts,J M
AU  - McNellis,D
TI  - Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
SN  - 0098-7484
PY  - 1997///1008
KW  - Adult
KW  - Amoxicillin
KW  - administration & dosage
KW  - Ampicillin
KW  - Carrier State
KW  - drug therapy
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - therapeutic use
KW  - Erythromycin
KW  - Female
KW  - Fetal Membranes, Premature Rupture
KW  - Humans
KW  - Infant, Newborn
KW  - Infant, Premature
KW  - Infant, Premature, Diseases
KW  - epidemiology
KW  - Pregnancy
KW  - Pregnancy Complications, Infectious
KW  - Pregnancy Outcome
KW  - Pregnancy Trimester, Second
KW  - Pregnancy Trimester, Third
KW  - Proportional Hazards Models
KW  - Statistics, Nonparametric
KW  - Streptococcal Infections
KW  - Streptococcus agalactiae
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
ER  -